Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 14Pain 13Pain, Postoperative 12Cancer Pain 10Agnosia 7Chronic Pain 6Colorectal Neoplasms 4Colonic Neoplasms 4Breast Neoplasms 4Neoplasm Metastasis 3Mucositis 3Lung Neoplasms 3Head and Neck Neoplasms 3Supratentorial Neoplasms 2Pancreatic Neoplasms 2Pain, Intractable 2Neoplastic Cells, Circulating 2Multiple Myeloma 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia, Biphenotypic, Acute 2Leukemia 2Inflammation 2Ileus 2Hematologic Neoplasms 2Wounds and Injuries 1Waldenstrom Macroglobulinemia 1Vesico-Ureteral Reflux 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

Tea 2Bupivacaine 2Tadalafil 1Supine Position 1Morphine 1Lidocaine 1Ketamine 1Injections, Subcutaneous 1Influenza Vaccines 1Head-Down Tilt 1Ethanol 1Dexmedetomidine 1Anesthetics, Local 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Abdominal Cancer × Morphine × Clear all
NCT02566096 2016-07-15

Efficacy of Transverses Abdominis -Plane Block With Bupivacaine Versus Bupivacaine With Morphine Postoperatively

Assiut University

Phase 4 Completed
60 enrolled

Abdominal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡